Office of the Chancellor

cutline goes here
Researchers are working to develop a treatment for cancerous tumors that would increase the effectiveness of chemotherapy drug regimens.

Researchers are working to develop a treatment for cancerous tumors that would increase the effectiveness of chemotherapy drug regimens.

Nanobiotechnology innovation shows promise and may lead to a treatment for cancerous tumors by a North Carolina start-up company

Building on emerging strengths in scientific discovery and technology transfer, UNCG entered into a license agreement with Thermiacure, Inc., a local start-up company located at the N.C. Nanoaccelerator, to further develop an innovation resulting from research at UNCG’s Center for Research Excellence in Nanobiosciences (CREN). The technology aims to develop a treatment for cancerous tumors that would increase the effectiveness of chemotherapy drug regimens by targeting the tumors and limiting the dosage. The outcome: better healing results and reduced side effects, such as hair loss and nausea, associated with current treatment methods. In addition to the three patent applications that cover the cancer diagnosis and treatment, another patent application has been submitted for the treatment of osteomyelitis, or bone infection, using novel nanoparticles.